These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7495944)

  • 1. Intravenous administration of lansoprazole: a preliminary study of dose ranging and efficacy in upper gastrointestinal bleeding.
    Aoki T
    Aliment Pharmacol Ther; 1995; 9 Suppl 1():51-7. PubMed ID: 7495944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24-hour intragastric pH in healthy subjects.
    Timmer W; Ripke H; Kleist P; Ehrlich A; Wieckhorst G; Lücker PW; Fuder H
    Methods Find Exp Clin Pharmacol; 1995 Sep; 17(7):489-95. PubMed ID: 8577212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response relationship of lansoprazole to gastric acid antisecretory effects.
    Blum RA; Hunt RH; Kidd SL; Shi H; Jennings DE; Greski-Rose PA
    Aliment Pharmacol Ther; 1998 Apr; 12(4):321-7. PubMed ID: 9690720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of intravenous lansoprazole on gastric acid hypersecretion in patients with postoperative stress.
    Otani Y; Kitajima M; Sugiyama M; Watanabe Y; Aoki T
    J Clin Gastroenterol; 1995; 20 Suppl 2():S22-6. PubMed ID: 7594333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori-negative healthy subjects.
    Geus WP; Mulder PG; Nicolai JJ; Van den Boomgaard DM; Lamers CB
    Aliment Pharmacol Ther; 1998 Apr; 12(4):329-35. PubMed ID: 9690721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring.
    Takeda H; Hokari K; Asaka M
    J Clin Gastroenterol; 1995; 20 Suppl 1():S7-9. PubMed ID: 7673616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lansoprazole regimens that sustain intragastric pH > 6.0: an evaluation of intermittent oral and continuous intravenous infusion dosages.
    Metz DC; Amer F; Hunt B; Vakily M; Kukulka MJ; Samra N
    Aliment Pharmacol Ther; 2006 Apr; 23(7):985-95. PubMed ID: 16573801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of lansoprazole on intragastric 24-hour pH, meal-stimulated gastric acid secretion, and concentrations of gastrointestinal hormones and enzymes in serum and gastric juice in healthy volunteers.
    Brunner G; Hell M; Hengels KJ; Hennig U; Fuchs W
    Digestion; 1995; 56(2):137-44. PubMed ID: 7750667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of omeprazole and lansoprazole on 24-hour intragastric pH in Helicobacter pylori-positive volunteers.
    Verdú EF; Fraser R; Armstrong D; Blum AL
    Scand J Gastroenterol; 1994 Dec; 29(12):1065-9. PubMed ID: 7886393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies of various administration methods for lansoprazole injection using 24-hour intragastric pH monitoring.
    Inoue M; Nakamura M
    J Clin Gastroenterol; 1995; 20 Suppl 2():S17-21. PubMed ID: 7594332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effect of lansoprazole and omeprazole on intragastric acidity and gastroesophageal reflux in patients with gastroesophageal reflux disease.
    Janczewska I; Sagar M; Sjöstedt S; Hammarlund B; Iwarzon M; Seensalu R
    Scand J Gastroenterol; 1998 Dec; 33(12):1239-43. PubMed ID: 9930385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determining the optimal dose of lansoprazole injection by 24-hour intragastric pH monitoring.
    Sugiyama M; Aoki T; Matsuo Y
    J Clin Gastroenterol; 1995; 20 Suppl 2():S14-6. PubMed ID: 7594331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasogastric lansoprazole is effective in suppressing gastric acid secretion in critically ill patients.
    Tsai WL; Poon SK; Yu HK; Chang CS; Yeh HZ; Ko CW; Chen GH
    Aliment Pharmacol Ther; 2000 Jan; 14(1):123-7. PubMed ID: 10632655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response evaluation of the antisecretory effect of continuous infusion intravenous lansoprazole regimens over 48 h.
    Howden CW; Metz DC; Hunt B; Vakily M; Kukulka M; Amer F; Samra N
    Aliment Pharmacol Ther; 2006 Apr; 23(7):975-84. PubMed ID: 16573800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative efficacy of lansoprazole and omeprazole on the intragastric pH measured over a period of 24 hours and on the basal].
    Paul G; Ramdani A; Mignon M; Vallot T; Forestier S; Cadiot G; Ruszniewski P; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(8-9):695-701. PubMed ID: 7875436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial and chronic gastric acid inhibition by lansoprazole and omeprazole in relation to meal administration.
    Brummer RJ; Geerling BJ; Stockbrügger RW
    Dig Dis Sci; 1997 Oct; 42(10):2132-7. PubMed ID: 9365148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
    Inatomi N; Murakami I; Asano S; Inada I; Satoh H
    Nihon Yakurigaku Zasshi; 1996 Dec; 108(6):333-43. PubMed ID: 9017687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dose-response effect of lansoprazole in patients with Zollinger-Ellison syndrome].
    Mignon M; Hochlaf S; Forestier S; Ruszniewski P; Vatier J; Joubert-Collin M
    Gastroenterol Clin Biol; 1994; 18(1):13-6. PubMed ID: 8187984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers.
    Bell NJ; Hunt RH
    Aliment Pharmacol Ther; 1996 Dec; 10(6):897-904. PubMed ID: 8971286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.